{ "release_id": "fc5a600ec7387e71", "id": "maternal:infant-rsv-disease", "owner": "maternal", "kind": "condition", "slug": "infant-rsv-disease", "name": "RSV lower respiratory tract disease in infants", "aliases": [ "RSV", "Respiratory syncytial virus" ], "atlases": [ "maternal" ], "summary_plain": "RSV (respiratory syncytial virus) is a common virus that usually causes a cold. In babies it can cause serious lung infections. Nearly all children catch RSV by age 2. There is no specific treatment for RSV infection. Two ways to protect babies from severe RSV illness are a vaccine given in pregnancy and an antibody injection given to the baby.", "summary_technical": "Descriptions from MedlinePlus and FDA's 2023 news release; no incidence figures are recorded. FDA calls RSV the most frequent cause of lower respiratory tract illness in infants worldwide and, citing CDC, the leading cause of infant hospitalisation in the United States. The two prevention routes in this atlas are RSV vaccination in pregnancy and an antibody given to the infant; each has its own page. The recipient differs by route.", "editorial_state": "draft", "last_substantive_edit": "2026-10-15", "last_evidence_check": "2026-10-15", "next_review_due": null, "identifiers": [], "navigation": { "maternal": { "life-stage": [ "newborn", "infant-follow-up" ], "care-area": [ "infant-health" ] } }, "payload": { "recognition": "In very young infants the only symptoms may be irritability, decreased activity and trouble breathing (MedlinePlus).", "assessment": "MedlinePlus says a lab test of nasal fluid or another respiratory specimen can check for RSV, usually for people with severe infection.", "burden_claims": [ "maternal:claim-infant-rsv-burden" ] }, "content_digest": "6ba87e682433602738a8e77130749c05fa763ee2e128318d6a94062e7559680f", "review": { "content_digest": "6ba87e682433602738a8e77130749c05fa763ee2e128318d6a94062e7559680f", "current": [], "conflicting": [], "stale": [], "inactive": [] }, "claims": [ { "release_id": "fc5a600ec7387e71", "id": "maternal:claim-infant-rsv-burden", "owner": "maternal", "subject_entity_id": "maternal:infant-rsv-disease", "category": "burden", "statement": "MedlinePlus describes RSV as a common respiratory virus that usually causes mild, cold-like symptoms but can cause serious lung infections, especially in infants, and says nearly all children become infected with RSV by age 2. In very young infants the only symptoms may be irritability, decreased activity and trouble breathing. FDA's 2023 news release called RSV the most frequent cause of lower respiratory tract illness in infants worldwide and, citing the Centers for Disease Control and Prevention, the leading cause of infant hospitalisation in the United States.", "context": { "id": "maternal:ctx-medlineplus-infants-rsv", "label": "Infants and young children and RSV (MedlinePlus and FDA descriptions)", "recipient": "child", "population": "Infants and young children, the group MedlinePlus and FDA describe as most affected by serious RSV illness. The MedlinePlus page also covers older adults and people with weakened immune systems, who are outside this context.", "care_setting": "Not stated (general health information and an FDA news release).", "geography": "General; the FDA statement about hospitalisation names the United States", "life_stage_note": "Infants from birth, and children up to about 2 years", "life_stage_terms": { "maternal": [ "newborn", "infant-follow-up" ] }, "gestational_age_min_days": null, "gestational_age_max_days": null, "gestational_age_basis": null, "postnatal_age_min_days": null, "postnatal_age_max_days": null, "gestational_age_status": null, "postnatal_age_status": null, "followup_description": "Not applicable (descriptive statements)", "eligibility": { "inclusion": [ "Infants and young children" ], "exclusion": [ "Not stated in the source that was read" ] } }, "evidence_stage": "not_applicable", "certainty": "not_assessed", "certainty_method": null, "limitations": "These are statements by a health information service and by FDA, not incidence studies, and neither gives numbers. The FDA statement about hospitalisation is FDA's report of a CDC statement; CDC's own source was not read.", "editorial_state": "draft", "checked_at": "2026-10-15", "next_review_due": null, "valid_from": null, "valid_to": null, "citations": [ { "evidence_role": "supports", "locator": "Summary, What is RSV?, sentences 1 and 2", "applicability_note": "MedlinePlus health topic summary.", "snapshot": { "id": "maternal:medlineplus-rsv-2026-10-15", "retrieved_at": "2026-10-15T13:49:53Z", "content_hash": "234a38a10cca920623a2eae8c2ac85ffb8edeb6ee17a5f6b9fe58d976db69de7", "source_effective_date": null, "public_archive_url": null, "source_state": "current" }, "source": { "id": "maternal:medlineplus-rsv", "source_type": "webpage", "title": "Respiratory Syncytial Virus Infections (MedlinePlus health topic)", "canonical_url": "https://medlineplus.gov/respiratorysyncytialvirusinfections.html", "identifiers": [], "publication_date": null, "publisher": "MedlinePlus, National Library of Medicine", "edition": "The health topic page as shown on 2026-10-15. The page carries no edition date.", "reuse_basis": "MedlinePlus page Linking to and Using Content (fetched as ml-medlineplus-using-content.html, sha256 f70c0b8c67574e30377aab0c22b44038364a37e2e9f54a2ffa67597383b3de34) lists summaries on health topic pages as public-domain content. The page bytes are not committed. Short quotations with attribution.", "public_text": "quote", "replaced_by": null, "retirement_note": null } }, { "evidence_role": "supports", "locator": "Summary, What is RSV?, sentence 3", "applicability_note": "MedlinePlus health topic summary.", "snapshot": { "id": "maternal:medlineplus-rsv-2026-10-15", "retrieved_at": "2026-10-15T13:49:53Z", "content_hash": "234a38a10cca920623a2eae8c2ac85ffb8edeb6ee17a5f6b9fe58d976db69de7", "source_effective_date": null, "public_archive_url": null, "source_state": "current" }, "source": { "id": "maternal:medlineplus-rsv", "source_type": "webpage", "title": "Respiratory Syncytial Virus Infections (MedlinePlus health topic)", "canonical_url": "https://medlineplus.gov/respiratorysyncytialvirusinfections.html", "identifiers": [], "publication_date": null, "publisher": "MedlinePlus, National Library of Medicine", "edition": "The health topic page as shown on 2026-10-15. The page carries no edition date.", "reuse_basis": "MedlinePlus page Linking to and Using Content (fetched as ml-medlineplus-using-content.html, sha256 f70c0b8c67574e30377aab0c22b44038364a37e2e9f54a2ffa67597383b3de34) lists summaries on health topic pages as public-domain content. The page bytes are not committed. Short quotations with attribution.", "public_text": "quote", "replaced_by": null, "retirement_note": null } }, { "evidence_role": "supports", "locator": "Summary, Who is at risk?, sentence 1 (part)", "applicability_note": "MedlinePlus health topic summary.", "snapshot": { "id": "maternal:medlineplus-rsv-2026-10-15", "retrieved_at": "2026-10-15T13:49:53Z", "content_hash": "234a38a10cca920623a2eae8c2ac85ffb8edeb6ee17a5f6b9fe58d976db69de7", "source_effective_date": null, "public_archive_url": null, "source_state": "current" }, "source": { "id": "maternal:medlineplus-rsv", "source_type": "webpage", "title": "Respiratory Syncytial Virus Infections (MedlinePlus health topic)", "canonical_url": "https://medlineplus.gov/respiratorysyncytialvirusinfections.html", "identifiers": [], "publication_date": null, "publisher": "MedlinePlus, National Library of Medicine", "edition": "The health topic page as shown on 2026-10-15. The page carries no edition date.", "reuse_basis": "MedlinePlus page Linking to and Using Content (fetched as ml-medlineplus-using-content.html, sha256 f70c0b8c67574e30377aab0c22b44038364a37e2e9f54a2ffa67597383b3de34) lists summaries on health topic pages as public-domain content. The page bytes are not committed. Short quotations with attribution.", "public_text": "quote", "replaced_by": null, "retirement_note": null } }, { "evidence_role": "supports", "locator": "Summary, What are the symptoms?, paragraph 2", "applicability_note": "MedlinePlus health topic summary.", "snapshot": { "id": "maternal:medlineplus-rsv-2026-10-15", "retrieved_at": "2026-10-15T13:49:53Z", "content_hash": "234a38a10cca920623a2eae8c2ac85ffb8edeb6ee17a5f6b9fe58d976db69de7", "source_effective_date": null, "public_archive_url": null, "source_state": "current" }, "source": { "id": "maternal:medlineplus-rsv", "source_type": "webpage", "title": "Respiratory Syncytial Virus Infections (MedlinePlus health topic)", "canonical_url": "https://medlineplus.gov/respiratorysyncytialvirusinfections.html", "identifiers": [], "publication_date": null, "publisher": "MedlinePlus, National Library of Medicine", "edition": "The health topic page as shown on 2026-10-15. The page carries no edition date.", "reuse_basis": "MedlinePlus page Linking to and Using Content (fetched as ml-medlineplus-using-content.html, sha256 f70c0b8c67574e30377aab0c22b44038364a37e2e9f54a2ffa67597383b3de34) lists summaries on health topic pages as public-domain content. The page bytes are not committed. Short quotations with attribution.", "public_text": "quote", "replaced_by": null, "retirement_note": null } }, { "evidence_role": "supports", "locator": "Paragraph 3, sentence 2", "applicability_note": "FDA news release.", "snapshot": { "id": "maternal:fda-abrysvo-press-2023-2026-10-15", "retrieved_at": "2026-10-15T13:49:54Z", "content_hash": "a9e38eeb5dbd394c4f249e8b4d31fc3c3355e93cb9f55b6dfe2607eb460623d9", "source_effective_date": "2023-08-22", "public_archive_url": null, "source_state": "current" }, "source": { "id": "maternal:fda-abrysvo-press-2023", "source_type": "regulator", "title": "FDA Approves First Vaccine for Pregnant Individuals to Prevent RSV in Infants (FDA news release)", "canonical_url": "https://www.fda.gov/news-events/press-announcements/fda-approves-first-vaccine-pregnant-individuals-prevent-rsv-infants", "identifiers": [], "publication_date": "2023-08-21", "publisher": "U.S. Food and Drug Administration", "edition": "Press announcement dated August 21, 2023. The page says its content was current as of 08/22/2023.", "reuse_basis": "FDA website policies page (fetched as ml-fda-website-policies.html, sha256 55a5b4fce88a043c5ae9dfb1f0ce276b5bd3cef79755ca246907c70272b848a1) says that, unless otherwise noted, the contents of www.fda.gov are not copyrighted, are in the public domain, and may be republished without permission. The bytes are not committed. Short quotations with attribution.", "public_text": "quote", "replaced_by": null, "retirement_note": null } }, { "evidence_role": "supports", "locator": "Paragraph 3, sentence 7", "applicability_note": "FDA news release.", "snapshot": { "id": "maternal:fda-abrysvo-press-2023-2026-10-15", "retrieved_at": "2026-10-15T13:49:54Z", "content_hash": "a9e38eeb5dbd394c4f249e8b4d31fc3c3355e93cb9f55b6dfe2607eb460623d9", "source_effective_date": "2023-08-22", "public_archive_url": null, "source_state": "current" }, "source": { "id": "maternal:fda-abrysvo-press-2023", "source_type": "regulator", "title": "FDA Approves First Vaccine for Pregnant Individuals to Prevent RSV in Infants (FDA news release)", "canonical_url": "https://www.fda.gov/news-events/press-announcements/fda-approves-first-vaccine-pregnant-individuals-prevent-rsv-infants", "identifiers": [], "publication_date": "2023-08-21", "publisher": "U.S. Food and Drug Administration", "edition": "Press announcement dated August 21, 2023. The page says its content was current as of 08/22/2023.", "reuse_basis": "FDA website policies page (fetched as ml-fda-website-policies.html, sha256 55a5b4fce88a043c5ae9dfb1f0ce276b5bd3cef79755ca246907c70272b848a1) says that, unless otherwise noted, the contents of www.fda.gov are not copyrighted, are in the public domain, and may be republished without permission. The bytes are not committed. Short quotations with attribution.", "public_text": "quote", "replaced_by": null, "retirement_note": null } } ], "review": { "content_digest": "14b57cf2e68513a21b28697cb403c098e3f68d440ffd673364e7ea6c1020a55d", "current": [], "conflicting": [], "stale": [], "inactive": [] }, "api_path": "api/v1/claims/maternal--claim-infant-rsv-burden.json" }, { "release_id": "fc5a600ec7387e71", "id": "maternal:claim-medlineplus-rsv-prevention-infants", "owner": "maternal", "subject_entity_id": "maternal:infant-rsv-disease", "category": "descriptive", "statement": "MedlinePlus says there is no specific treatment for RSV infection. It says there are two medicines to help prevent severe RSV illness in babies and young children, that these medicines cannot cure or treat children who already have RSV, and that one of them is given to infants who are younger than 8 months during their first RSV season.", "context": { "id": "maternal:ctx-medlineplus-infants-rsv", "label": "Infants and young children and RSV (MedlinePlus and FDA descriptions)", "recipient": "child", "population": "Infants and young children, the group MedlinePlus and FDA describe as most affected by serious RSV illness. The MedlinePlus page also covers older adults and people with weakened immune systems, who are outside this context.", "care_setting": "Not stated (general health information and an FDA news release).", "geography": "General; the FDA statement about hospitalisation names the United States", "life_stage_note": "Infants from birth, and children up to about 2 years", "life_stage_terms": { "maternal": [ "newborn", "infant-follow-up" ] }, "gestational_age_min_days": null, "gestational_age_max_days": null, "gestational_age_basis": null, "postnatal_age_min_days": null, "postnatal_age_max_days": null, "gestational_age_status": null, "postnatal_age_status": null, "followup_description": "Not applicable (descriptive statements)", "eligibility": { "inclusion": [ "Infants and young children" ], "exclusion": [ "Not stated in the source that was read" ] } }, "evidence_stage": "guidance", "certainty": "not_assessed", "certainty_method": null, "limitations": "A plain-language summary. The page does not name the medicines. A monoclonal antibody for infants (nirsevimab) is on its own page, and the page's text on older children and on other prevention steps was not recorded here.", "editorial_state": "draft", "checked_at": "2026-10-15", "next_review_due": null, "valid_from": null, "valid_to": null, "citations": [ { "evidence_role": "supports", "locator": "Summary, What are the treatments?, sentence 1", "applicability_note": "MedlinePlus health topic summary.", "snapshot": { "id": "maternal:medlineplus-rsv-2026-10-15", "retrieved_at": "2026-10-15T13:49:53Z", "content_hash": "234a38a10cca920623a2eae8c2ac85ffb8edeb6ee17a5f6b9fe58d976db69de7", "source_effective_date": null, "public_archive_url": null, "source_state": "current" }, "source": { "id": "maternal:medlineplus-rsv", "source_type": "webpage", "title": "Respiratory Syncytial Virus Infections (MedlinePlus health topic)", "canonical_url": "https://medlineplus.gov/respiratorysyncytialvirusinfections.html", "identifiers": [], "publication_date": null, "publisher": "MedlinePlus, National Library of Medicine", "edition": "The health topic page as shown on 2026-10-15. The page carries no edition date.", "reuse_basis": "MedlinePlus page Linking to and Using Content (fetched as ml-medlineplus-using-content.html, sha256 f70c0b8c67574e30377aab0c22b44038364a37e2e9f54a2ffa67597383b3de34) lists summaries on health topic pages as public-domain content. The page bytes are not committed. Short quotations with attribution.", "public_text": "quote", "replaced_by": null, "retirement_note": null } }, { "evidence_role": "supports", "locator": "Summary, Can RSV infections be prevented?, paragraph 3", "applicability_note": "MedlinePlus health topic summary.", "snapshot": { "id": "maternal:medlineplus-rsv-2026-10-15", "retrieved_at": "2026-10-15T13:49:53Z", "content_hash": "234a38a10cca920623a2eae8c2ac85ffb8edeb6ee17a5f6b9fe58d976db69de7", "source_effective_date": null, "public_archive_url": null, "source_state": "current" }, "source": { "id": "maternal:medlineplus-rsv", "source_type": "webpage", "title": "Respiratory Syncytial Virus Infections (MedlinePlus health topic)", "canonical_url": "https://medlineplus.gov/respiratorysyncytialvirusinfections.html", "identifiers": [], "publication_date": null, "publisher": "MedlinePlus, National Library of Medicine", "edition": "The health topic page as shown on 2026-10-15. The page carries no edition date.", "reuse_basis": "MedlinePlus page Linking to and Using Content (fetched as ml-medlineplus-using-content.html, sha256 f70c0b8c67574e30377aab0c22b44038364a37e2e9f54a2ffa67597383b3de34) lists summaries on health topic pages as public-domain content. The page bytes are not committed. Short quotations with attribution.", "public_text": "quote", "replaced_by": null, "retirement_note": null } }, { "evidence_role": "supports", "locator": "Summary, Can RSV infections be prevented?, paragraph 3, sentence 2", "applicability_note": "MedlinePlus health topic summary.", "snapshot": { "id": "maternal:medlineplus-rsv-2026-10-15", "retrieved_at": "2026-10-15T13:49:53Z", "content_hash": "234a38a10cca920623a2eae8c2ac85ffb8edeb6ee17a5f6b9fe58d976db69de7", "source_effective_date": null, "public_archive_url": null, "source_state": "current" }, "source": { "id": "maternal:medlineplus-rsv", "source_type": "webpage", "title": "Respiratory Syncytial Virus Infections (MedlinePlus health topic)", "canonical_url": "https://medlineplus.gov/respiratorysyncytialvirusinfections.html", "identifiers": [], "publication_date": null, "publisher": "MedlinePlus, National Library of Medicine", "edition": "The health topic page as shown on 2026-10-15. The page carries no edition date.", "reuse_basis": "MedlinePlus page Linking to and Using Content (fetched as ml-medlineplus-using-content.html, sha256 f70c0b8c67574e30377aab0c22b44038364a37e2e9f54a2ffa67597383b3de34) lists summaries on health topic pages as public-domain content. The page bytes are not committed. Short quotations with attribution.", "public_text": "quote", "replaced_by": null, "retirement_note": null } }, { "evidence_role": "supports", "locator": "Summary, Can RSV infections be prevented?, paragraph 4, sentence 1", "applicability_note": "MedlinePlus health topic summary.", "snapshot": { "id": "maternal:medlineplus-rsv-2026-10-15", "retrieved_at": "2026-10-15T13:49:53Z", "content_hash": "234a38a10cca920623a2eae8c2ac85ffb8edeb6ee17a5f6b9fe58d976db69de7", "source_effective_date": null, "public_archive_url": null, "source_state": "current" }, "source": { "id": "maternal:medlineplus-rsv", "source_type": "webpage", "title": "Respiratory Syncytial Virus Infections (MedlinePlus health topic)", "canonical_url": "https://medlineplus.gov/respiratorysyncytialvirusinfections.html", "identifiers": [], "publication_date": null, "publisher": "MedlinePlus, National Library of Medicine", "edition": "The health topic page as shown on 2026-10-15. The page carries no edition date.", "reuse_basis": "MedlinePlus page Linking to and Using Content (fetched as ml-medlineplus-using-content.html, sha256 f70c0b8c67574e30377aab0c22b44038364a37e2e9f54a2ffa67597383b3de34) lists summaries on health topic pages as public-domain content. The page bytes are not committed. Short quotations with attribution.", "public_text": "quote", "replaced_by": null, "retirement_note": null } } ], "review": { "content_digest": "43cb7ed5f393cf6be0ca3c0eb03e9312d8eb53b486cf07278b2abf582b8a506f", "current": [], "conflicting": [], "stale": [], "inactive": [] }, "api_path": "api/v1/claims/maternal--claim-medlineplus-rsv-prevention-infants.json" } ], "decisions": [], "milestones": [], "relationships": { "outgoing": [ { "predicate": "part_of", "label": "Filed under this front", "clinical_claim_not_fact": false, "family": "navigation", "other_entity_id": "maternal:front-medicines-and-vaccines", "other_entity_in_atlas": true, "claim_id": null, "evidence": null, "primary": true, "role": null, "valid_from": null, "valid_to": null } ], "incoming": [ { "predicate": "related_to", "label": "Related to", "clinical_claim_not_fact": false, "family": "navigation", "other_entity_id": "maternal:infant-immunization", "other_entity_in_atlas": true, "claim_id": null, "evidence": null, "primary": false, "role": null, "valid_from": null, "valid_to": null }, { "predicate": "evaluated_for", "label": "Evaluated for this", "clinical_claim_not_fact": true, "family": "clinical", "other_entity_id": "maternal:nirsevimab", "other_entity_in_atlas": true, "claim_id": "maternal:claim-melody-ma-rsv-lrti", "evidence": null, "primary": false, "role": null, "valid_from": null, "valid_to": null }, { "predicate": "evaluated_for", "label": "Evaluated for this", "clinical_claim_not_fact": true, "family": "clinical", "other_entity_id": "maternal:nirsevimab", "other_entity_in_atlas": true, "claim_id": "maternal:claim-melody-hospitalisation", "evidence": null, "primary": false, "role": null, "valid_from": null, "valid_to": null }, { "predicate": "evaluated_for", "label": "Evaluated for this", "clinical_claim_not_fact": true, "family": "clinical", "other_entity_id": "maternal:maternal-rsv-vaccination", "other_entity_in_atlas": true, "claim_id": "maternal:claim-matisse-severe-rsv-lrti-efficacy", "evidence": null, "primary": false, "role": null, "valid_from": null, "valid_to": null }, { "predicate": "evaluated_for", "label": "Evaluated for this", "clinical_claim_not_fact": true, "family": "clinical", "other_entity_id": "maternal:maternal-rsv-vaccination", "other_entity_in_atlas": true, "claim_id": "maternal:claim-matisse-any-rsv-lrti-90-days", "evidence": null, "primary": false, "role": null, "valid_from": null, "valid_to": null } ] }, "page_path": "conditions/infant-rsv-disease/", "context_path": "api/v1/context/maternal--infant-rsv-disease.md" }